BiomX (PHGE) Operating Expenses (2018 - 2026)
BiomX's (PHGE) quarterly Operating Expenses came in at $5.4 million in Q2 2026, down 27.58% year-over-year from $7.4 million in Q2 2025, and up 315.35% quarter-over-quarter from $1.3 million in Q1 2026.
Analysis
BiomX (PHGE) Operating Expenses (2018 - 2026) Analysis & Trends
BiomX has disclosed Operating Expenses across 9 years of filings, most recently posting $5.4 million for Q2 2026.
- In Q2 2026, Operating Expenses fell 27.58% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $12.0 million (down 45.74% YoY), while the FY2025 annual figure was $30.9 million, down 17.5% from the prior year.
- Operating Expenses came in at $5.4 million for Q2 2026 at BiomX, up from $1.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $9.7 million in Q2 2024 to a low of -$2.4 million in Q3 2024.
- Average Operating Expenses over 5 years is $5.3 million, with a median of $6.4 million recorded in 2022.
- The largest YoY upside for Operating Expenses was 78.34% in 2024 against a maximum downside of 130.96% in 2024.
- Over 5 years, Operating Expenses stood at $5.2 million in 2022, then gained by 1.78% to $5.3 million in 2023, then surged by 78.34% to $9.4 million in 2024, then retreated by 23.47% to $7.2 million in 2025, then declined by 25.18% to $5.4 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $5.4 million in Q2 2026, $1.3 million in Q1 2026, and $7.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 367.83 Mn |
| 10 | BiomX | 17.33 Mn | 16.75 Mn | 97,000.00 | 5.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.38 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 7.20 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 7.76 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | -2.41 Mn |
| Jun 30, 2024 | 9.73 Mn |
| Dec 31, 2023 | 5.27 Mn |
| Sep 30, 2023 | 7.80 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 565,000.00 |
| Dec 31, 2022 | 5.18 Mn |
| Sep 30, 2022 | 6.43 Mn |
| Jun 30, 2022 | 7.14 Mn |
| Mar 31, 2022 | 7.41 Mn |
| Dec 31, 2021 | 14.03 Mn |
| Sep 30, 2021 | 9.90 Mn |
| Jun 30, 2021 | 6.92 Mn |